GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (TSXV:LXG.H) » Definitions » Cyclically Adjusted PB Ratio

Lexagene Holdings (TSXV:LXG.H) Cyclically Adjusted PB Ratio : 10.50 (As of Jun. 06, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Lexagene Holdings Cyclically Adjusted PB Ratio?

As of today (2024-06-06), Lexagene Holdings's current share price is C$0.105. Lexagene Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Nov. 2022 was C$0.01. Lexagene Holdings's Cyclically Adjusted PB Ratio for today is 10.50.

The historical rank and industry rank for Lexagene Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSXV:LXG.H's Cyclically Adjusted PB Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.1
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lexagene Holdings's adjusted book value per share data for the three months ended in Nov. 2022 was C$0.012. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$0.01 for the trailing ten years ended in Nov. 2022.

Shiller PE for Stocks: The True Measure of Stock Valuation


Lexagene Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Lexagene Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Cyclically Adjusted PB Ratio Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.99 1.46 3.23 7.74 6.97

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.86 6.97 6.50 9.11 15.29

Competitive Comparison of Lexagene Holdings's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Lexagene Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexagene Holdings's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Cyclically Adjusted PB Ratio falls into.



Lexagene Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Lexagene Holdings's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.105/0.01
=10.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lexagene Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Nov. 2022 is calculated as:

For example, Lexagene Holdings's adjusted Book Value per Share data for the three months ended in Nov. 2022 was:

Adj_Book=Book Value per Share/CPI of Nov. 2022 (Change)*Current CPI (Nov. 2022)
=0.012/125.6074*125.6074
=0.012

Current CPI (Nov. 2022) = 125.6074.

Lexagene Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201212 -0.057 96.871 -0.074
201303 -0.112 98.209 -0.143
201306 -0.162 98.518 -0.207
201309 -0.132 98.790 -0.168
201312 -0.109 98.326 -0.139
201403 -0.188 99.695 -0.237
201406 0.038 100.560 0.047
201409 0.012 100.428 0.015
201412 0.009 99.070 0.011
201503 0.004 99.621 0.005
201506 0.012 100.684 0.015
201509 0.009 100.392 0.011
201512 0.005 99.792 0.006
201603 -0.008 100.470 -0.010
201606 -0.012 101.688 -0.015
201609 0.014 101.861 0.017
201702 0.028 102.779 0.034
201705 0.045 103.256 0.055
201708 0.033 103.587 0.040
201711 0.018 104.072 0.022
201802 0.074 105.052 0.088
201805 0.046 106.148 0.054
201808 0.091 106.383 0.107
201811 0.051 106.338 0.060
201902 0.027 106.649 0.032
201905 0.033 108.048 0.038
201908 0.019 108.245 0.022
201911 0.056 108.519 0.065
202002 0.057 109.139 0.066
202005 0.038 108.175 0.044
202008 0.047 109.662 0.054
202011 0.118 109.793 0.135
202102 0.117 110.968 0.132
202105 0.087 113.576 0.096
202108 0.066 115.421 0.072
202111 0.040 117.269 0.043
202202 0.059 119.703 0.062
202205 0.041 123.323 0.042
202208 0.024 124.958 0.024
202211 0.012 125.607 0.012

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lexagene Holdings  (TSXV:LXG.H) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Lexagene Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (TSXV:LXG.H) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (TSXV:LXG.H) Headlines

No Headlines